1. Home
  2. PTCT vs WTM Comparison

PTCT vs WTM Comparison

Compare PTCT & WTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • WTM
  • Stock Information
  • Founded
  • PTCT 1998
  • WTM 1980
  • Country
  • PTCT United States
  • WTM Bermuda
  • Employees
  • PTCT N/A
  • WTM 893
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • WTM Property-Casualty Insurers
  • Sector
  • PTCT Health Care
  • WTM Finance
  • Exchange
  • PTCT Nasdaq
  • WTM Nasdaq
  • Market Cap
  • PTCT 4.1B
  • WTM 4.4B
  • IPO Year
  • PTCT 2013
  • WTM N/A
  • Fundamental
  • Price
  • PTCT $60.65
  • WTM $1,721.50
  • Analyst Decision
  • PTCT Buy
  • WTM
  • Analyst Count
  • PTCT 14
  • WTM 0
  • Target Price
  • PTCT $67.00
  • WTM N/A
  • AVG Volume (30 Days)
  • PTCT 1.2M
  • WTM 30.9K
  • Earning Date
  • PTCT 11-06-2025
  • WTM 11-05-2025
  • Dividend Yield
  • PTCT N/A
  • WTM 0.06%
  • EPS Growth
  • PTCT N/A
  • WTM N/A
  • EPS
  • PTCT 7.72
  • WTM 79.93
  • Revenue
  • PTCT $1,764,929,000.00
  • WTM $2,578,600,000.00
  • Revenue This Year
  • PTCT $119.89
  • WTM N/A
  • Revenue Next Year
  • PTCT N/A
  • WTM N/A
  • P/E Ratio
  • PTCT $7.88
  • WTM $21.46
  • Revenue Growth
  • PTCT 96.00
  • WTM 12.16
  • 52 Week Low
  • PTCT $33.88
  • WTM $1,678.87
  • 52 Week High
  • PTCT $62.18
  • WTM $2,023.00
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 69.46
  • WTM 38.83
  • Support Level
  • PTCT $58.87
  • WTM $1,700.00
  • Resistance Level
  • PTCT $62.18
  • WTM $1,785.77
  • Average True Range (ATR)
  • PTCT 2.13
  • WTM 32.65
  • MACD
  • PTCT 0.52
  • WTM -11.03
  • Stochastic Oscillator
  • PTCT 88.43
  • WTM 14.33

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About WTM White Mountains Insurance Group Ltd.

White Mountains Insurance Group Ltd is engaged in the business of making opportunistic and value-oriented acquisitions of businesses and assets in the insurance, financial services, and related sectors, operating these businesses and assets through its subsidiaries and, if and when attractive exit valuations become available, disposing of these businesses and assets. The company conducts its business in five areas: property and casualty insurance and reinsurance, municipal bond reinsurance, capital solutions for asset and wealth management firms, property and casualty insurance distribution, and other operations.

Share on Social Networks: